Cassava Sciences, Inc.
SAVA
$2.74
$0.166.20%
| Weiss Ratings | SAVA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | SAVA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SAVA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.33 | |||
| Price History | SAVA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 10.48% | |||
| 30-Day Total Return | 16.60% | |||
| 60-Day Total Return | -3.86% | |||
| 90-Day Total Return | -89.67% | |||
| Year to Date Total Return | -0.36% | |||
| 1-Year Total Return | -86.83% | |||
| 2-Year Total Return | -89.31% | |||
| 3-Year Total Return | -91.60% | |||
| 5-Year Total Return | -15.95% | |||
| 52-Week High % Change | -93.89% | |||
| 52-Week Low % Change | 15.70% | |||
| Price | SAVA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $42.20 | |||
| 52-Week Low Price | $2.23 | |||
| 52-Week Low Price (Date) | Dec 20, 2024 | |||
| 52-Week High Price (Date) | Aug 05, 2024 | |||
| Valuation | SAVA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 124.63M | |||
| Enterprise Value | -3.94M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.45 | |||
| Earnings Per Share Growth | -37.55% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.85 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $2.74 | |||
| Enterprise Value/EBITDA (TTM) | 0.03 | |||
| Enterprise Value/EBIT | 0.03 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | SAVA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 48.10M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $5.25 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $5.25 | |||
| Company Info | SAVA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 512 501 2444 | |||
| Address | 6801 N. Capital of Texas Highway Austin, TX 78731 | |||
| Website | www.cassavasciences.com | |||
| Country | United States | |||
| Year Founded | 1998 | |||
| Profitability | SAVA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | SAVA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -53.63% | |||
| Return on Equity | -- | |||
| Income Statement | SAVA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 7.73M | |||
| EBITDA (TTM) | -131.51M | |||
| EBIT (TTM) | -132.65M | |||
| Net Income (TTM) | -24.34M | |||
| Net Income Avl. to Common (TTM) | -24.34M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -31.92% | |||
| EPS Diluted (TTM) | -1.45 | |||
| EPS Diluted Growth (Q YOY) | -14.60% | |||
| Balance Sheet | SAVA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 128.57M | |||
| Cash Per Share (Q) | $2.67 | |||
| Total Current Assets (Q) | 136.53M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 145.70M | |||
| Current Ratio (Q) | 11.620 | |||
| Book Value Per Share (Q) | $3.02 | |||
| Total Assets (Q) | 157.53M | |||
| Total Current Liabilities (Q) | 11.75M | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 11.83M | |||
| Total Common Equity (Q) | 145.70M | |||
| Cash Flow | SAVA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -103.00K | |||
| Cash from Financing (TTM) | 124.47M | |||
| Net Change in Cash (TTM) | 7.44M | |||
| Levered Free Cash Flow (TTM) | -67.49M | |||
| Cash from Operations (TTM) | -116.93M | |||
